Catalyst Wire Dossier Catalyst Wire Dossier

Theralugand

lutetium-177 chloride · Eckert & Ziegler Radiopharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Theralugand, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: EMA Authorised: Theralugand (lutetium (177Lu) chloride) — Eckert & Ziegler Radiopharma GmbH

See pricing